Noom Med with Smart Rx , in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit such that the payer can choose the level of financial assistance they will provide Noom Weight with GLP-1 Rx delivers a proven obesity program and employee-pay access to affordable GLP-1s for employers who choose not to cover GLP-1s today New York, NY October 21, 2024 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is tackling the problem of GLP-1 availability, accessibility and inflated costs head-on by launching two distinct enterprise solutions that reduce obesity management costs while enabling access to life-changing medications: Noom Med with Smart Rx in partnership with Waltz Health and Noom Weight with GLP-1 Rx
GLP-1 medications start low and increase gradually
The most common issues are gastrointestinal such as nausea, vomiting, diarrhea, constipation, and stomach discomfort
Add Supportive Therapies Combining semaglutide with other interventions may help: B-vitamin injections for energy and metabolism Adaptogens to regulate cortisol and stress response Metabolic supplements like L-carnitine or omega-3s (as recommended by a provider) 6
That can help explain possible mechanisms, but it cannot establish the safety, effectiveness, or ideal schedule of the combination
Healthcare providers should provide training at treatment initiation, with periodic reassessment to reinforce correct practices